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Abstract
Background The aim of the present study was to evaluate whether serum C-reactive protein (CRP) is a useful predictor of
early post-operative complications, particularly of intestinal leaks after laparoscopic Roux-en-Y gastric bypass (LRYGB)
surgery.
Methods The present study was a retrospective analysis of a prospectively maintained database with 809 patients who
underwent LRYGB from 2002 until 2011. For 410 of these patients, at least one CRP measurement within the first seven
post-operative days was available. The diagnostic value was determined by the area under the curve (AUC) of the receiver
operating characteristic (ROC) curve.
Results Forty-nine of 410 patients (12.0 %; 95 % confidence intervals [95 % CI], 9.2–15.5 %) developed surgery-related
complications. Leaks occurred in 17 patients (4.1 %; 95 % CI, 2.6–6.5 %) at a median of 5 days after surgery. CRP levels
2 days after surgery showed the highest diagnostic value for post-operative complications (AUC, 0.74; 95 % CI, 0.60–0.89).
Sensitivity was 0.53 (95 % CI, 0.31–0.74) and specificity was 0.91 (95 % CI, 0.79–0.96) on day 2 (cutoff level, 229 mg/l).
The sensitivity for intestinal leaks was 1.00 (95 % CI, 0.51–1.00).
Conclusion CRP on post-operative day 2 is a valuable predictor of post-operative complications, in particular intestinal
leaks. Radiological imaging studies for intestinal leaks could be restricted to patients with CRP values exceeding 229 mg/l.
Keywords Laparoscopic Roux-en-Y gastric bypass .
Post-operative complication . Leak . C-reactive protein
Introduction
Gastric bypass procedures for morbidly obese patients are
associated with a considerable morbidity.1 Especially,
intestinal leaks can have serious consequences leading to
an increased mortality.2 Early detection of these complica-
tions is extremely important since timely treatment
improves the clinical outcome and reduces mortality.3–7
Many bariatric surgeons routinely perform upper gastroin-
testinal (GI) series to detect anastomotic problems in time.8–13
However, the diagnostic value of the upper GI series is quite
limited; thus, some authors propose a more selective strategy
using the upper GI series only on clinically symptomatic
patients.10–12,14–16
It has been demonstrated that the post-operative C-
reactive protein (CRP) serum level can predict septic com-
plications after open visceral operations, such as colorectal,
gastro-oesophageal and pancreatic surgery.17–22 The serum
CRP level on post-operative day 4 (POD 4) has consistently
been found to have the best diagnostic value using cutoff
levels around 140 mg/l CRP. CRP measurements are rela-
tively inexpensive, widely available and clinically well-
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established.23–25 However, little is known about CRP as a
predictor of complications after laparoscopic procedures.
Therefore, we performed a study assessing the predictive
value of CRP levels for general post-operative complications
and especially intestinal leaks after laparoscopic Roux-en-Y
gastric bypass (LRYGB) surgery.
Material and Methods
Study Design and Endpoints
This study was a retrospective diagnostic cohort study in-
cluding all severely obese patients operated on with a
LRYGB procedure between January 1, 2002 and February
28, 2011 at our institution. Data were derived from a prospec-
tivelymaintained database. SerumCRP level was evaluated as
predictor for 30-day morbidity and intestinal anastomotic
leaks.
Study Outcome Measures and Definitions
Post-operative mortality was defined as any death within
30 days after surgery. Study outcome measures were the
following surgery-related complications: leaks of the gastro-
jejunal and ileo-ileal anastomosis, staple line leaks, stenosis,
bleeding, ulcers of the gastrojejunal anastomosis, the ileo-
ileal anastomosis and the remnant stomach, intra-abdominal
bleeding, internal and trocar site hernias, ileus, wound infec-
tions and pancreatic injuries. If a patient required surgical
revisions, only CRP measurements performed before the
revision surgery were included in this study. Intestinal leak
was defined as the presence of contrast agent outside of the
GI tract in radiology examination or proof of anastomotic
leakage upon reoperations. General complications were de-
fined as all non-surgical complications.
Eligibility Criteria for Patients
Patients with at least one CRP measurement between day 2
and day 7 after surgery were included in the final analysis.
The indication for surgery was based on the guidelines of a
Consensus Development Conference Panel of the National
Institutes of Health and on the Consensus on Obesity Treat-
ment in Switzerland.26,27 Patients converted to an open
gastric bypass operation as well as patients with previous
bariatric surgeries except gastric banding were excluded
from the study.
Perioperative Management
All patients routinely received pre-operative antibiotic prophy-
laxis (500 mg metronidazole IV and 2,000 mg cefamandole
IV) 60 min before surgery and a digestive tract decontamina-
tion from the day of surgery until radiological control of the
anastomosis with a solution of polymyxin (100 mg), tobramy-
cin (80 mg), vancomycin (125 mg) and nystatin (500 mg),
administered orally four times a day.
Anticoagulation was achieved with low-molecular-
weight heparin adjusted for body weight and individual
thromboembolic risk according to the patient’s clinical
history. Between POD 3 and 6, upper GI series were
conducted for all patients using an oral water-soluble contrast
agent.
Table 1 Distribution and onset of post-operative complications (n0410)
Frequency,
N (%)
Onset, median
(IQR), days
Any surgery-related complication 49 (12.0) 4 (2–9)
Leakage of gastro-jejunostomy 4 (1.0) 5 (4–7)
Stenosis of gastro-jejunostomy 5 (1.2) 22 (9–30)
Ulcer of gastro-jejunostomy 1 (0.2) 23
Staple line leak of remnant stomach 4 (1.0) 5 (5–5)
Staple line leak at gastric pouch 8 (2.0) 5 (3–7)
Total bleeding 10 (2.4) 3 (2–9)
Bleeding of gastro-jejunostomy 4 (1.0)
Bleeding of small bowel 3 (0.7)
Extra-luminal bleeding 3 (0.7)
Bowel obstruction 10 (2.4) 4 (3–11)
Small bowel 5 (1.2)
Jejuno-jejunostomy 1 (0.2)
Hernia 4 (1.0)
Perforation 2 (0.5) 9 (4–26)
Small bowel 1 (0.2)
Gastric 1 (0.2)
Pancreatic complications 1 (0.2) 1
Superficial infection 4 (1.0) 1 (1–6)
Other complicationsa 4 (1.0) 1 (0–10)
Treatment of surgery-related
complications
Conservative treatment 16 (3.9)
Laparoscopic revision 13 (3.2)
Open revision 20 (4.9)
Any general complication 32 (7.8) 3 (1–7)
Pulmonary 13 (3.2)
Cardiac 3 (0.7)
Allergic reaction 3 (0.7)
Neurological 0 (0.0)
GI 4 (1.0)
Urological 8 (2.0)
Other 1 (0.2)
IQR interquartile range
a Other0technical failure, abdominal compartment, choledochus steno-
sis, infarction of spleen
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Surgical Procedure
One surgeon (MT) performed or at least supervised all
procedures. Six ports were placed for the LRYGB proce-
dure. In all patients, a 15- to 20-ml gastric pouch was
created as the restrictive component. Gut limb lengths were
systematically varied according to the patient’s body mass
index (BMI), co-morbidities, eating habits and psychosocial
situation.
CRP Measurements
Serum CRP concentrations were measured with an automat-
ed analytical system (Unicel DxC 800, Beckman Coulter,
Brea, CA, USA). The reference range was defined as <8 mg/l;
the detection range was 3–300 mg/l until August 2005, after-
wards 3–500 mg/l. For this study, CRP values exceeding
300 mg/l were reduced to 300 mg/l to allow comparability
of high values from both periods.
Statistical Analysis
Statistical analysis was performed using SAS software, ver-
sion 9.1 (SAS Institute, Cary, NC, USA) and R environment
software, version 2.12.1 (http://www.r-project.org). Contin-
uous data are expressed as the median and interquartile
range (IQR). Chi-square test was used to compare categor-
ical data, and the Mann–Whitney U test was used to com-
pare continuous data. Two-sided p values of <0.05 were
considered to be statistically significant. Ninety-five percent
confidence intervals (95 % CI) of proportions (including
sensitivity, etc.) were calculated with the Wilson score
method.28 Predictive values were prevalence-adjusted
(e.g. PPV0sensitivity×prevalence/(sensitivity×prevalence+
(1−specificity)×(1−prevalence))). The diagnostic value was
determined by the area under the curve (AUC) of the receiver
operating characteristic (ROC) curve,29 and the 95 % confi-
dence limits of the AUCs were determined according to the
method of DeLong.30 For each POD, the CRP level with the
highest Youden’s index (equals sensitivity+specificity−1) for
the outcome 30-day morbidity was used as cutoff. The same
cutoffs were used to determine the diagnostic accuracy for
intestinal leaks. The present study was approved by the Swiss
Federal Expert Commission for Physician Confidentiality and
the local ethics review board.
Results
Demographics and Clinical Data
Between January 2002 and February 2011, 809 patients
underwent LRYGB surgery; however, for 399, no CRP
measurements had been performed. After excluding these
patients, 410 patients remained for analysis, all with com-
plete clinical data until day 30 after surgery. None of the
patients died within 30 days of surgery (95 % CI, 0–0.9 %).
The overall complication rate for patients included in the
study, i.e. those with at least one post-operative CRP mea-
surement, was 18.8 % (77 of 410; 95 % CI, 15.3–22.8 %)
including surgery-related and general complications. The
rates for each type of complication are summarized in Table 1.
Surgery-related complications occurred in 49 of the 410
patients (12.0 %; 95 % CI, 9.2–15.5 %), with a median
incidence time of 4 days after the surgery (IQR, 2–9 days).
Thirty-three patients required surgical revisionswithin 30 days
of surgery (8.1 %; 95 % CI, 5.8–11.1 %).
Intestinal leaks occurred in 17 patients (4.1 %; 95 % CI,
2.6–6.5 %), occurring at a median of 5 days post-operatively
(IQR, 4–5 days). Five of the 17 (29.4 %) patients with
intestinal leaks were treated conservatively with antibiotics
and total parenteral nutrition. One patient additionally need-
ed computed tomography (CT)-guided drainage. Two
patients (11.8 %) were re-operated laparoscopically, and in
the remaining ten patients (58.8 %), a revisional laparotomy
was performed. In three patients with intestinal leaks, no
upper GI series were performed. One of them directly un-
derwent diagnostic laparoscopy because of the clinical pre-
sentation, and in the other two, a CT scan with oral contrast
agents was primarily performed. Upper GI series detected
Table 2 Patients characteristics
Data are presented as the
median (IQR) and N (%)
LRYGB laparoscopic
Roux-en-Y gastric bypass
aChi-square test
bMann–Whitney U test
Total, n0410 Surgery-related or general complications p value
Yes (n077) No (n0333)
Gender Male 95 (23.2 %) 26 (33.8 %) 69 (20.7 %) 0.014a
Female 315 (76.8 %) 51 (66.2 %) 264 (79.3 %)
Age (years) 44 (36–52) 45 (38–52) 44 (35–52) 0.199b
BMI (kg/m2) 46 (42–50) 45 (42–52) 46 (42–50) 0.824b
Any additional operation 346 (84.4 %) 62 (80.5 %) 284 (85.3 %) 0.299a
Operation time (min) 195 (153–240) 230 (166–280) 185 (150–236) 0.002b
Length of hospital stay (days) 7 (6–8) 8 (7–14) 7 (6–8) <0.001b
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the leak in 8 of the 14 patients tested, yielding a sensitivity
of 57.1 % (95 % CI, 32.6–78.6 %). For five of these eight
patients, CRP measurements between POD 2 and POD 5
were available which all exceeded the cutoff value. Of
the six patients with a negative upper GI series, five
were tested with a CT scan and oral contrast agent, and
in each case, the test result was positive. The remaining
patient underwent a diagnostic laparoscopy. For five of
the six patients with a false-negative upper GI series,
CRP measurements between POD 2 and POD 5 were
available. Four of these patients had CRP levels exceeding the
cutoff value, while one, measured on POD 3, was below the
cutoff.
A total of 32 patients suffered from complications not
related to surgery (7.8 %; 95 % CI, 5.6–10.8 %), with a
median occurrence of 3 days post-operatively (IQR, 1–
7 days). Complications occurred less often in the 399
patients excluded due to lacking CRP measurements, with
a significantly lower overall complication rate of 8.5 % (34
of 399; 95 % CI, 6.2–11.7 %; p<0.001) and a significantly
lower leakage rate of 0.5 % (2 of 399; 95 % CI, 0.1–1.8 %;
p00.001). Clinical data of patients with and without post-
operative complications are summarized in Table 2. Com-
plications were more prevalent in males. Operating time and
hospital stay were increased with statistical significance in
patients with complications.
Post-Operative Time Course of CRP Levels
At our institution, CRP levels are routinely measured before
surgery. The median CRP serum level before surgery was
7 mg/l and there was no difference between patients with or
without complications (Table 3). On day 2 after surgery,
serum CRP increased considerably in all patients; however,
for patients with complications, the median CRP level was
about double the level of patients without complications
(Table 3). Furthermore, in patients without complications,
the CRP levels declined more rapidly than in patients with
complications.
Diagnostic Value of CRP Levels
The AUC of the ROC curve for the 30-day morbidity was
between 0.71 and 0.74 for post-operative day 2 to 7 (Fig. 1).
Thus, the diagnostic value for the 30-day morbidity was
generally low to moderate. The highest sensitivity (100 %)
could be observed on POD 5 and 7 and the highest speci-
ficity on POD 2 (Table 4). On POD 2, sensitivity was
53 % and specificity was 91 %; on POD 3 and POD 4,
sensitivity was 76 and 77 % and specificity was 74 and 66 %,
respectively.
Sensitivity and specificity on day 2, depending on the
CRP threshold, are depicted in Fig. 2. Using the cutoff
Table 3 Post-operative time course of CRP levels
Total Surgery-related or general complications p valuea
N CRP (mg/l) Yes No
N CRP (mg/l) N CRP (mg/l))
Pre-operative 284 7 (4–12) 45 7 (4–12) 239 7 (4–12) 0.945
POD 2 61 129 (80–199) 17 229 (120–295) 44 113 (78–173) 0.004
POD 3 56 110 (64–200) 17 189 (124–275) 39 100 (62–172) 0.008
POD 4 63 70 (44–121) 22 97 (72–248) 41 55 (37–93) 0.003
POD 5 42 81 (38–131) 14 112 (50–170) 28 59 (29–123) 0.026
POD 6 61 51 (29–83) 19 89 (32–213) 42 43 (24–63) 0.010
POD 7 44 61 (35–105) 18 74 (51–167) 26 46 (27–87) 0.010
Data are presented as the median (IQR)
aMann–Whitney U test
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values obtained for the 30-day morbidity, the sensitivity for
leaks was 100 % on each POD, except POD 3. Furthermore,
all patients with an intestinal leak (diagnosed at POD 3,
POD 4 (n02) and POD 5) were correctly predicted. How-
ever, nine patients were false positively predicted, resulting
in specificities of 84, 60, 56 and 28 % from POD 2 to POD 5
(Table 4).
Cost-effectiveness of Routine CRP Measurements
On POD 2, about 80 % of the patients had a CRP level
below the cutoff value and none of them developed an
anastomotic leak. Thus, radiological imaging could be limited
to the 20 % of patients exceeding the cutoff. Assuming 15 €
per CRP measurement and 400 € per radiological imaging,
this will result in a saving of 300 € per patient.
Discussion
This study assessed the diagnostic value of CRP for the
prediction of early post-operative complications in a large
number of patients undergoing LRYGB surgery. On POD 2,
the best diagnostic values for general complications and for
intestinal leaks were observed. Particularly, the sensitivity
for intestinal leaks reached 100 %. Based on these results,
the upper GI series might be restricted to patients exceeding
the CRP cutoff level of 229 mg/l.
The diagnostic value of the upper GI series to detect
intestinal leaks after LRYGB surgery is rather low, resulting
in far too many false-positive or false-negative results.10–12,14
Therefore, some authors have suggested to abandon its routine
performance and to restrict radiological examinations to
patients with clinical symptoms, like respiratory distress or
tachycardia.10,11,15,16 Besides lowering costs, such an ap-
proach would also spare a large number of patients the expo-
sure to medical radiation associated with an increased lifetime
cancer risk.31 On the other hand, relying solely on clinical
symptoms will occasionally lead to delayed diagnosis of
intestinal leaks.2 Considering that early detection of post-
operative leaks is important to prevent mortality,2,6,7
the diagnostic window of a solely clinical-based approach,
as described above, might be too wide.
The present study suggests that CRP measurements on
POD 2 could potentially overcome this problem. While the
CRP level is certainly not specific enough to diagnose an
intestinal leak, it appears sufficient to correctly exclude this
kind of complication in about 80 % of the patients being at
risk. On this background, only the remaining 20 % of
patients showing an above cutoff CRP level at POD 2 would
have to undergo an upper GI series. Thus, a CRP-based
approach could lead to a reduced number of falsely diagnosed
patients, to a lower individual radiation exposure and to a
considerable cost reduction. While some surgeons might be
hesitant to submit a nauseated patient with equivocal findings
for a post-operative complication to an upper GI series or a CT
scan, we would suggest performing these diagnostic proce-
dures in case of elevated CRP values. While some patients
might suffer the discomfort of an unnecessary exam, others
would benefit from the early treatment of an impending com-
plication, particularly since nausea can be reduced by antie-
metic treatment. If the upper GI series are not part of the
routine work-up, CRP levels below the cutoff level might
identify patients not at risk of having a leakage or post-
operative infectious complication, allowing a safe and early
discharge. In contrast, elevated CRP levels should raise
suspicion for complication and trigger further diagnostic
measures.
Given its great cost-saving potential, the CRP-based ap-
proach would even allow for repeated imaging studies in
patients with clinical symptoms, while the overall cost
would be still lower than with a routine imaging approach.12
Furthermore, one may consider to perform a CT scan with
oral contrast agents on the selected patients instead of the
upper GI series, since this imaging technique is more sensitive
to detect leaks.32,33
While CRP appears to be valuable in regard to selecting
patients for radiological examinations, it is not sufficient to
reliably predict general post-operative complications. Here,
the best positive predictive value (PPV; on POD 2) was only
57 %. Thus, for the diagnosis of general complications, CRP
levels obviously need to be interpreted within the context of
post-operative clinical symptoms.
In contrast to other studies in which the best diag-
nostic values for complications were observed on POD
4 or even later, in the present study, the highest diagnostic
CRP (mg/L)
Se
ns
itiv
ity
/S
pe
cif
ici
ty
0 5 100 150 200 250 300
0.
0
0.
1
0.
2
0.
3
0.
4
0.
5
0.
6
0.
7
0.
8
0.
9
1.
0
Sensitivity
Specificity
95%CI cut−off (229 mg/L)
Fig. 2 Influence of threshold on diagnostic values on day 2. Sensitiv-
ity and specificity are plotted against the CRP levels on POD 2,
together with the 95 % confidence levels (dashed lines). The cutoff
level according to the Youden’s index is depicted with an arrow
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value was already observed on POD 2.17–22 It should be
noted that these foregoing studies predominantly inves-
tigated open surgeries, such as colorectal, gastro-oesophageal
and pancreatic operations, and no evidence exists if and
how far these findings can be transferred to gastric bypass
surgery. Particularly, no evidence exists about lower CRP
values after laparoscopic compared to open bypass surgery.
Since there is some evidence that the immunological
stress response is weaker after laparoscopic than after open
procedures, one could speculate that the post-operative
increase of CRP is weaker and CRP levels return more
quickly back to normal values after laparoscopy.34–37
Supporting this view, in the present study, the average
peak CRP level after surgery in patients without com-
plications was 110 mg/l, while in previous studies investigat-
ing open surgeries, the respective level was on average
200 mg/l. Also, due to the enhanced surgical trauma, it
appears to be impossible to distinguish between a regular
post-operative stress response and impending complications
upon CRP levels measured at POD 2 and 3 after open
surgery. Only after the fourth post-operative day, i.e.
when CRP levels usually drop already, CRP levels became
diagnostic for complications after open surgery.17–22 The
present retrospective study provides first evidence that, after
laparoscopy, CRP levels can be indicative for impending
complications much earlier, i.e. on POD 2. However, prospec-
tive trials are clearly needed to ascertain this assumption
because it is questionable whether the magnitude and dynam-
ics of CRP levels after different operations in different patients
are comparable.
The 30-day morbidity in our series was comparable to
previous reports, indicating that our patient population can
be considered representative.38–43 The median hospital stay
was longer than reported in other studies, which is explained
by the current hospital policy in Switzerland with reim-
bursement based on hospital stay rather than diagnosis-
related groups. For a diagnostic study, however, this might
actually be favourable since post-operative complications
are more reliably diagnosed during hospitalisation than after
discharge.
The main limitation of this study is its retrospective
design. Nearly half of the patients with a LRYGB operation
were not included in the study due to lacking CRP measure-
ments. The lack of CRP measurements could reflect the
absence of any clinical symptom prompting such a measure-
ment. In turn, in patients included in the study, the CRP
measurement was most likely performed in response to
his/her clinical presentation, which could also have bi-
ased the time point of measurement. Also, the retrospec-
tive design did not allow for evaluating specific clinical
parameters with sufficient reliability; thus, symptoms
like fever, tachycardia or pain were not assessed in this
study.
Conclusion
In conclusion, the present results suggest that CRP measure-
ments should be routinely performed 2 days after LRYGB
surgery in order to exclude impendent complications and
leaks in particular. By doing so, radiological imaging exami-
nations for intestinal leaks could be restricted to patients
with serum CRP levels above 229 mg/l on POD 2. If the
suggested reliability of this diagnostic approach is con-
firmed in prospective trials, many patients could be spared
from upper GI series, leading to meaningful reduction of
health care costs.
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